The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma

Belinda Lee; Annie Wong; Damien Kee; Paul J. Neeson; Mark Shackleton; Grant A. McArthur; Shahneen Sandhu

doi:10.1093/annonc/mdw056

Related publications

Article1992

Abnormal neuroendocrine immune communications in patients with rheumatoid arthritis

Ian C. Chikanza, George Chrousos, G S Panayi

Article2021

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis

Kaarina Kowalec, Heather Carney, Mitulkumar Patel, Carol Hitchon, James M. Bolton, Scott Burton Patten, Lesley A. Graff, Çharles N. Bernstein, Christine Peschken, Ruth Ann Marrie

Letter2021

Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma – Authors' reply

Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers, Allison Betof Warner, James R. Patrinely, Patricio Serra-Bellver, Clara Allayous, Joanna Mangana, Lisa Zimmer, Claudia Trojaniello, Oliver Klein, Camille L. Gérard, Olivier Michielin, Andrew Haydon, Paolo A. Ascierto, Matteo S. Carlino, Célèste Lebbé, Paul Lorigan, Douglas B. Johnson, Shahneen Sandhu, Serigne Lo, Alexander M. Menzies, Georgina V. Long

Article1992

Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis

Ian C. Chikanza, Petros Petrou, Gabrielle Kingsley, George Chrousos, G S Panayi

Article2018

Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study

Usman Khalid, Alexander Egeberg, Ole Ahlehoff, Deirdre A. Lane, Gunnar Gislason, Professor Gregory Lip, Peter Riis Hansen